Hepatitis B

  • 2023/12 - Recommendations (Pdf, 1023 Kb) on the 2024 vaccination schedule

    March 2024 update, with corrections and clarifications in Part B. Overview of recommended vaccinations.

  • 2019/12 - Recommendations (Pdf, 778 Kb) on the vaccination of babies born prematurely

    The Superior Council of Infectious Diseases (Conseil supérieur des maladies infectieuses - CSMI) recommends vaccinating babies born prematurely (i.e. before 37 weeks of amenorrhoea) as follows: 1) depending on the child's age 2) by supplementing the universal vaccination schedule with an additional dose: 2.1.) of pneumococcal conjugate vaccine (3+1 schedule, at 8, 12, 16 weeks, then at one year), for premature babies < 33 weeks, or < 1,500 g; 2.2.) of hepatitis B vaccine (3+1 schedule, at 8, 12, 16 weeks, then at one year), for premature babies <2,000 g; 3) by supplementing the universal vaccination schedule with: 3.1.) a seasonal influenza vaccine dose, for premature babies < 33 weeks, for the first two winter seasons; 3.2.) RSV (respiratory syncytial virus) immunisation, for premature babies who are at risk during the winter season. In addition, the CSMI recommends checking and updating the vaccination status of those in the premature baby's family circle – especially as regards whooping cough – and vaccinating them against seasonal influenza during the child's first two winters.

  • 2011/12 - Recommendations (Pdf, 56 Kb) on hepatitis B vaccination

    the Superior Council of Infectious Diseases (CSMI) – formerly the Conseil supérieur d’hygiène – recommends: 17 years after its initial recommendations, the CSMI still recommends hepatitis B vaccination for all infants. At-risk individuals who have not yet been vaccinated should still be vaccinated. Unvaccinated pregnant women should be tested for the hepatitis B surface antigen (HbsAg) at the end of their pregnancy, and babies whose mothers are HbsAg-positive should receive anti-HBV immunoglobulins and the first vaccine dose at birth. Based on current scientific knowledge, there is no need to administer a vaccine booster dose in otherwise healthy children and adults. Except in certain categories of patients – see list below – there is no need to perform a post-vaccination serology test. In addition to these recommendations, this circular contains information on the epidemiology of hepatitis B and the reasons for vaccination; the spread of the HBV virus; HBV vaccination and duration of protection; persons who should be vaccinated etc.

Last update